Cerus reported $33.33M in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Cerus USD 33.33M 8.66M Dec/2024
GRIFOLS EUR 686.84M 56.95M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Neogen USD 99M 7.7M Dec/2025
OraSure Technologies USD 11.34M 435K Dec/2025
Plus Therapeutics 1.37M 30K Dec/2025
Quidel USD -91.8M 366.6M Mar/2026
Rockwell Medical USD 4.55M 1.49M Jun/2024
STAAR Surgical USD 43.74M 34.13M Dec/2025
Terumo JPY 149.02B 4.17B Mar/2026
Utah Medical Products USD 5.8M 450K Sep/2024